- Tags: IOLs
Research
New data finds increased prevalence of refractive surgery among cataract patients
Clinicians may need to consider new ways of calculating IOL power due to prevalence of high myopia and previous refractive surgery.
Pipeline
SpyGlass Pharma raises $75M to advance sustained-release drug delivery platform
Financing to support upcoming phase 3 trials on the company’s long-term delivery system of bimatoprost for glaucoma and OHT treatment.
Products
Haag-Streit launches corneal map for the Lenstar 900
The optical biometer’s newest integratable feature enables simultaneous measurement of a wider range of biometric parameters for cataract surgery planning.
Pipeline
FDA OKs clinical trial on Atia Vision's novel IOL for cataract patients
IDE approval brings company one step closer toward seeking regulatory clearance for the OmniVu Lens System, a dual-optic IOL.
Research
SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system
Presented at ASCRS, new findings show promising visual outcomes and IOP lowering following sustained-release delivery of bimatoprost.
Products
Alcon debuts new digital platform for clinics and surgery centers
Designed for use within the Alcon Vision Suite, this cloud-based platform connects clinics’ patient and surgery data to a surgery center.
Research
Clinical outcomes support JJV's violet-filtering IOL for glaucoma
New research on the Tecnis Symfony OptiBlue IOL shows promising visual outcomes just one week after implantation post-cataract surgery.
Products
B+L's enVista IOLs return to market after voluntary recall
Company announces conclusion of investigation into reported cases of TASS involving the enVista IOL product line.
Products
Alcon launches Clareon PanOptix Pro IOL in the US
With a broad commercial rollout planned for next month, this will be the company’s first presbyopia-correcting IOL available in its Clareon AutonoMe preloaded system.
Products
B+L issues voluntary recall of certain IOLs in enVista platform
Recall follows an increase in reports of toxic anterior segment syndrome connected to implants of the enVista Aspire, Envy, and other monofocal IOLs.
Research
Which is more effective for astigmatism: toric IOLs or FSAK?
Despite comparable clinical outcomes, toric IOLs may have better efficacy for moderate and ATR astigmatism.
Business
Staar Surgical appoints new CEO amid leadership changes
Global healthcare executive veteran Stephen C. Farrell takes over the helm as Elizabeth Yeu, MD, is named board chair of STAAR’s Board of Directors.
Pipeline
Rayner completes enrollment for US study on first-ever spiralized IOL
Already commercially available in Europe, the AI-developed RayOne Galaxy IOL offers a full range of focus, minimized dysphotopsia, and 0% loss of transmitted light.
Products
Nidek's NP-T Preloaded Toric IOL Injection System makes global debut
System features a two-step process with an aspheric hydrophobic soft acrylic toric lens and average absolute rotation of 2.1°± 1.7° from 1 hour to 6 months postoperatively.
Research
Researchers develop fluorescent gel device for cataract surgery
Johns Hopkins University researchers tested a new color-changing hydrogel intended to reduce post-cataract surgery complications.
Products
FDA approves Bausch + Lomb's en Vista Envy IOL
Offering a continuous range of vision with excellent dysphotopsia tolerance, the lens will be initially available on a limited basis.
Products
J&J expands US rollout of TECNIS Odyssey IOL
Purely refractive presbyopia-correcting lens provides full visual range with minimal visual complaints and higher tolerance to residual refractive errors.
Products
Global IOL injector maker debuts line of sustainable, single-use instruments
Environmentally-friendly, single-use IOL injector and I/A handpiece features a 51% smaller carbon footprint vs standard systems.
Products
Alcon program guides clinical practices on advanced technology
Designed for surgeons and staff, the Accelerator program targets patient-focused outcomes for advanced technology IOL recommendations.
Products